Hinge Health, Inc.
Close on Oct 19, 2026
- Market cap
- $8.67B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 3, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 4, 2026 | After market close | $212.80M | $0.52 | $0.59 |
| Q1 FY2026 Ended Mar 31, 2026 | May 5, 2026 | After market close | $182.30M | $0.41 | $0.45 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 10, 2026 | After market close | $170.70M | $0.37 | $0.49 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 4, 2025 | After market close | $154.20M | $-0.02 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 5, 2025 | After market close | $139.10M | – | – |
Company guidance
Outlook given with results on Aug 4, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| non-GAAP income from operations guidancenon-GAAP | Full Year 2026 | $236.00M to $244.00M | Raised |
| non-GAAP income from operationsnon-GAAP | Q3 2026 | $61.00M to $63.00M | New |
| revenue guidance | Full Year 2026 | $856.00M to $860.00M | Raised |
| revenue | Q3 2026 | $223.00M to $225.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Hinge Health filed with the SEC
Hinge Health reports record second quarter 2026 financial results; signs definitive agreement to acquire Cylinder Health
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Hinge Health to acquire Cylinder Health, expanding into gastrointestinal care
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Hinge Health hosts its first Investor Day and raises guidance
Regulation FD disclosure · EX-99.1 to Form 8-K
Hinge Health reports record first quarter 2026 financial results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Hinge Health reports fourth quarter and full year 2025 financial results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Hinge Health announces $250 million share repurchase program
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Hinge Health reports third quarter 2025 financial results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Hinge Health Reports Second Quarter 2025 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K